Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study

10.1200/JCO.2016.67.2048

Saved in:

Bibliographic Details
Main Authors:	Nogova, Lucia, Sequist, Lecia V, Garcia, Jose Manuel Perez, Andre, Fabrice, Delord, Jean-Pierre, Hidalgo, Manuel, Schellens, Jan HM, Cassier, Philippe A, Camidge, D Ross, Schuler, Martin, Vaishampayan, Ulka, Burris, Howard, Tian, G Gary, Campone, Mario, Wainberg, Zev A, Lim, Wan-Teck, LoRusso, Patricia, Shapiro, Geoffrey I, Parker, Katie, Chen, Xueying, Choudhury, Somesh, Ringeisen, Francois, Graus-Porta, Diana, Porter, Dale, Isaacs, Randi, Buettner, Reinhard, Wolf, Juergen
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Language:	English
Published:	AMER SOC CLINICAL ONCOLOGY 2024
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology PROTEIN EXPRESSION FGFR1 CARCINOMA SENSITIVITY NVP-BGJ398 MUTATIONS DOCETAXEL NIVOLUMAB DRIVERS BLADDER
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/248922
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-248922
record_format	dspace
spelling	sg-nus-scholar.10635-2489222024-11-11T21:42:06Z Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study Nogova, Lucia Sequist, Lecia V Garcia, Jose Manuel Perez Andre, Fabrice Delord, Jean-Pierre Hidalgo, Manuel Schellens, Jan HM Cassier, Philippe A Camidge, D Ross Schuler, Martin Vaishampayan, Ulka Burris, Howard Tian, G Gary Campone, Mario Wainberg, Zev A Lim, Wan-Teck LoRusso, Patricia Shapiro, Geoffrey I Parker, Katie Chen, Xueying Choudhury, Somesh Ringeisen, Francois Graus-Porta, Diana Porter, Dale Isaacs, Randi Buettner, Reinhard Wolf, Juergen DUKE-NUS MEDICAL SCHOOL Assoc Prof Wan-Teck Darren Lim Science & Technology Life Sciences & Biomedicine Oncology PROTEIN EXPRESSION FGFR1 CARCINOMA SENSITIVITY NVP-BGJ398 MUTATIONS DOCETAXEL NIVOLUMAB DRIVERS BLADDER 10.1200/JCO.2016.67.2048 JOURNAL OF CLINICAL ONCOLOGY 35 2 157-+ 2024-06-15T02:56:04Z 2024-06-15T02:56:04Z 2017-01-10 2024-06-12T14:06:51Z Article Nogova, Lucia, Sequist, Lecia V, Garcia, Jose Manuel Perez, Andre, Fabrice, Delord, Jean-Pierre, Hidalgo, Manuel, Schellens, Jan HM, Cassier, Philippe A, Camidge, D Ross, Schuler, Martin, Vaishampayan, Ulka, Burris, Howard, Tian, G Gary, Campone, Mario, Wainberg, Zev A, Lim, Wan-Teck, LoRusso, Patricia, Shapiro, Geoffrey I, Parker, Katie, Chen, Xueying, Choudhury, Somesh, Ringeisen, Francois, Graus-Porta, Diana, Porter, Dale, Isaacs, Randi, Buettner, Reinhard, Wolf, Juergen (2017-01-10). Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study. JOURNAL OF CLINICAL ONCOLOGY 35 (2) : 157-+. ScholarBank@NUS Repository. https://doi.org/10.1200/JCO.2016.67.2048 0732-183X 1527-7755 https://scholarbank.nus.edu.sg/handle/10635/248922 en AMER SOC CLINICAL ONCOLOGY Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Oncology PROTEIN EXPRESSION FGFR1 CARCINOMA SENSITIVITY NVP-BGJ398 MUTATIONS DOCETAXEL NIVOLUMAB DRIVERS BLADDER
spellingShingle	Science & Technology Life Sciences & Biomedicine Oncology PROTEIN EXPRESSION FGFR1 CARCINOMA SENSITIVITY NVP-BGJ398 MUTATIONS DOCETAXEL NIVOLUMAB DRIVERS BLADDER Nogova, Lucia Sequist, Lecia V Garcia, Jose Manuel Perez Andre, Fabrice Delord, Jean-Pierre Hidalgo, Manuel Schellens, Jan HM Cassier, Philippe A Camidge, D Ross Schuler, Martin Vaishampayan, Ulka Burris, Howard Tian, G Gary Campone, Mario Wainberg, Zev A Lim, Wan-Teck LoRusso, Patricia Shapiro, Geoffrey I Parker, Katie Chen, Xueying Choudhury, Somesh Ringeisen, Francois Graus-Porta, Diana Porter, Dale Isaacs, Randi Buettner, Reinhard Wolf, Juergen Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
description	10.1200/JCO.2016.67.2048
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Nogova, Lucia Sequist, Lecia V Garcia, Jose Manuel Perez Andre, Fabrice Delord, Jean-Pierre Hidalgo, Manuel Schellens, Jan HM Cassier, Philippe A Camidge, D Ross Schuler, Martin Vaishampayan, Ulka Burris, Howard Tian, G Gary Campone, Mario Wainberg, Zev A Lim, Wan-Teck LoRusso, Patricia Shapiro, Geoffrey I Parker, Katie Chen, Xueying Choudhury, Somesh Ringeisen, Francois Graus-Porta, Diana Porter, Dale Isaacs, Randi Buettner, Reinhard Wolf, Juergen
format	Article
author	Nogova, Lucia Sequist, Lecia V Garcia, Jose Manuel Perez Andre, Fabrice Delord, Jean-Pierre Hidalgo, Manuel Schellens, Jan HM Cassier, Philippe A Camidge, D Ross Schuler, Martin Vaishampayan, Ulka Burris, Howard Tian, G Gary Campone, Mario Wainberg, Zev A Lim, Wan-Teck LoRusso, Patricia Shapiro, Geoffrey I Parker, Katie Chen, Xueying Choudhury, Somesh Ringeisen, Francois Graus-Porta, Diana Porter, Dale Isaacs, Randi Buettner, Reinhard Wolf, Juergen
author_sort	Nogova, Lucia
title	Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
title_short	Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
title_full	Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
title_fullStr	Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
title_full_unstemmed	Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
title_sort	evaluation of bgj398, a fibroblast growth factor receptor 1-3 kinase inhibitor, in patients with advanced solid tumors harboring genetic alterations in fibroblast growth factor receptors: results of a global phase i, dose-escalation and dose-expansion study
publisher	AMER SOC CLINICAL ONCOLOGY
publishDate	2024
url	https://scholarbank.nus.edu.sg/handle/10635/248922
_version_	1821185910018932736

Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study

Similar Items